IHS Chemical Week

EnviroTech :: Biotech

Amyris Secures $83.7 Million in Financing

3:08 PM MST | February 27, 2012 | Rebecca Coons

 Amyris says it has secured $83.7 million in financing to fund working capital, two weeks after the company told investors it was having trouble maintaining peak yields and  was scaling back efforts to ramp up production of farnesene, its first commercial product.   The financing included a $58.7 million private placement of common stock and $25 million in aggregate principal amount of 3% senior unsecured notes due 2017.  The private placement included existing Amyris investors  Temasek Holdings, Total Gas & Power USA...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa